Albert Chau

974 total citations
25 papers, 397 citations indexed

About

Albert Chau is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Albert Chau has authored 25 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Albert Chau's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). Albert Chau is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). Albert Chau collaborates with scholars based in United States, United Kingdom and Norway. Albert Chau's co-authors include WK Leung, Sam K. S. Ng, Penelope Ward, David M. Schuster, Peter T. Nieh, Frode Willoch, Lucia Zanoni, Cristina Nanni, Tore Bach‐Gansmo and Stefano Fanti and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Albert Chau

22 papers receiving 387 citations

Peers

Countries citing papers authored by Albert Chau

Since Specialization

Citations

This map shows the geographic impact of Albert Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Chau more than expected).

Fields of papers citing papers by Albert Chau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Chau. The network helps show where Albert Chau may publish in the future.

Co-authorship network of co-authors of Albert Chau

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Chau. A scholar is included among the top collaborators of Albert Chau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Chau. Albert Chau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review 2025 ·Diagnostics ·Soroush Rais‐Bahrami, (unknown), Albert Chau, Samuel J. Galgano, Brian F. Chapin, David M. Schuster, (unknown)	0
2	Trauma-informed care in medical imaging: A scoping review of current practices and best practice recommendations 2025 ·Radiography ·(unknown), Nayana Parange, (unknown), Albert Chau, (unknown)	0
3	What are the causes and outcomes of malpractice litigation in medical imaging technologists and sonographers? A scoping review 2025 ·Radiography ·C. Clifton Ling, (unknown), Albert Chau, Nayana Parange	0
4	Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study 2024 ·Advances in Radiation Oncology ·Benjamin Lowentritt, Ashesh B. Jani, Brian T. Helfand, Edward Uchio, Michael A. Morris, (unknown), Albert Chau, (unknown), Brian F. Chapin, David M. Schuster	4
5	PPV of Bone Uptake of ¹⁸F-Flotufolastat: Evaluation Using SPOTLIGHT Study Data 2024 ·American Journal of Roentgenology ·David M. Schuster, Ashesh B. Jani, Charles Marcus, Albert Chau, (unknown)	2
6	18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study 2024 ·Advances in Radiation Oncology ·Soroush Rais‐Bahrami, Mark T. Fleming, Benjamin A. Gartrell, William C. Lavely, Albert Chau, (unknown), David M. Schuster	1
7	True-Positive¹⁸F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study 2024 ·Journal of Nuclear Medicine ·Mark T. Fleming, Rick Hermsen, Andrei S. Purysko, Albert Chau, (unknown), Brian F. Chapin, David M. Schuster	2
8	The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association–defined Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: A Phase 1b Study 2024 ·European Urology Open Science ·F. Johannes P. van Valenberg, Antoine G. van der Heijden, (unknown), Sumeet Bhanvadia, Kirk A. Keegan, Shalaka Hampras, Hussein Sweiti, (unknown), (unknown), Albert Chau, Donald L. Reynolds, (unknown), (unknown), Xiang Li, (unknown), J.P. Michiel Sedelaar, (unknown), Diederik M. Somford, J.A. Witjes	11
9	Interreader and Intrareader Reproducibility of¹⁸F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies 2024 ·Journal of Nuclear Medicine ·Phillip H. Kuo, Giuseppe Esposito, Gary A. Ulaner, Don C. Yoo, Katherine Zukotynski, Gregory Ravizzini, R. H. C. Penny, Matthew P. Miller, Albert Chau, (unknown), Brian F. Chapin, David M. Schuster, (unknown)	2
10	Impact of standard-of-truth method on evaluation of a diagnostic PET radiopharmaceutical: Learnings from the phase 3 SPOTLIGHT study. 2024 ·Journal of Clinical Oncology ·Benjamin Lowentritt, Albert Chau, (unknown)	1
11	Evaluating the diagnostic performance of ¹⁸F-fluciclovine for detection of recurrent brain metastases after radiation therapy: Results from a prospective phase 2 trial. 2023 ·Journal of Clinical Oncology ·Rupesh Kotecha, Veronica Chiang, Martin C. Tom, Ali Nabavizadeh, Elçin Zan, (unknown), Erik P. Sulman, Barry A. Siegel, Jiayi Huang, Steven Brem, Marcus Ware, Santosh Kesari, Ephraim E. Parent, Whitney B. Pope, (unknown), Albert Chau, Eugene Teoh, Samuel T. Chao, Mariam Aboian, (unknown)	4
12	Reply by Authors 2023 ·The Journal of Urology ·Ashesh B. Jani, Gregory Ravizzini, Benjamin A. Gartrell, Barry A. Siegel, Przemyslaw Twardowski, Daniel R. Saltzstein, Mark T. Fleming, Albert Chau, (unknown), Brian F. Chapin, David M. Schuster	2
13	The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial 2022 ·Urologic Oncology Seminars and Original Investigations ·Siamak Daneshmand, Iris Brummelhuis, Kamal S. Pohar, Gary D. Steinberg, Manju Aron, (unknown), Kirk A. Keegan, (unknown), Donald L. Reynolds, (unknown), Albert Chau, J.A. Witjes	18
14	A Nationwide Population Based Analysis of Organ-Confined Muscle-Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014. 2019 ·The Journal of Urology ·(unknown), Truls Gårdmark, Lars Lindhagen, Albert Chau, Per‐Uno Malmström	1
15	A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014 2019 ·The Journal of Urology ·(unknown), Truls Gårdmark, Lars Lindhagen, Albert Chau, Per‐Uno Malmström	35
16	Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases 2018 ·Clinical Nuclear Medicine ·Albert Chau, Peter Gardiner, Patrick M. Colletti, Hossein Jadvar	12
17	Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using ¹⁸F-Fluciclovine PET/CT 2017 ·Journal of Nuclear Medicine ·Matthew P. Miller, Lale Kostakoğlu, Daniel A. Pryma, Jian Q. Yu, Albert Chau, Eric S. Perlman, (unknown), (unknown), Penelope Ward	26
18	Impact of 18 F-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Eugene Teoh, David Bottomley, Andrew Scarsbrook, Heather Payne, Asim Afaq, (unknown), N. van As, Sue Chua, Peter Hoskin, Anthony L. Chambers, Gary Cook, Victoria Warbey, Albert Chau, Penelope Ward, (unknown), Daniel Stevens, L.D. Wilson, Fergus Gleeson	5
19	Multisite experience of fluciclovine (¹⁸F) PET/CT imaging in biochemically recurrent prostate cancer: Impact of clinical factors and intersite variation. 2017 ·Journal of Clinical Oncology ·Lucia Zanoni, Cristina Nanni, Tore Bach‐Gansmo, Trond Velde Bogsrud, Peter T. Nieh, (unknown), (unknown), (unknown), Funmilayo Tade, Oluwaseun Odewole, Penelope Ward, Albert Chau, Mark Goodman, Stefano Fanti, David M. Schuster, Frode Willoch	1
20	The effect of pre‐operative information in relieving anxiety in oral surgery patients 2004 ·Community Dentistry And Oral Epidemiology ·Sam K. S. Ng, Albert Chau, WK Leung	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact